The Use of Central Laboratories and Remote Electronic Data Capture to Risk-Adjust Therapy for Pediatric Acute Lymphoblastic Leukemia and Neuroblastoma : Cancer prediction modelsDEVIDAS, Meenakshi; LONDON, Wendy B; ANDERSON, James R et al.Seminars in oncology. 2010, Vol 37, Num 1, pp 53-59, issn 0093-7754, 7 p.Article

Criteria for optimizing prognostic risk groups in pediatric cancer: Analysis of data from the Children's Oncology GroupSPOSTO, Richard; LONDON, Wendy B; ALONZO, Todd A et al.Journal of clinical oncology. 2007, Vol 25, Num 15, pp 2070-2077, issn 0732-183X, 8 p.Article

Treatment and outcome of 83 children with intraspinal neuroblastoma : The Pediatric Oncology Group ExperienceKATZENSTEIN, Howard M; KENT, Paul M; LONDON, Wendy B et al.Journal of clinical oncology. 2001, Vol 19, Num 4, pp 1047-1055, issn 0732-183XArticle

A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants: A Children's Oncology Group StudyNUCHTERN, Jed G; LONDON, Wendy B; SHAMBERGER, Robert C et al.Annals of surgery. 2012, Vol 256, Num 4, pp 573-579, issn 0003-4932, 7 p.Conference Paper

Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group ProjectMOROZ, Veronica; MACHIN, David; MATTHAY, Katherine K et al.European journal of cancer (1990). 2011, Vol 47, Num 4, pp 561-571, issn 0959-8049, 11 p.Article

miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor SamplesDE PRETER, Katleen; MESTDAGH, Pieter; HOGARTY, Michael D et al.Clinical cancer research (Print). 2011, Vol 17, Num 24, pp 7684-7692, issn 1078-0432, 9 p.Article

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid : A Children's Oncology Group StudyMATTHAY, Katherine K; REYNOLDS, C. Patrick; SEEGER, Robert C et al.Journal of clinical oncology. 2009, Vol 27, Num 7, pp 1007-1013, issn 0732-183X, 7 p.Article

Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcomeQIWEI YANG; KIERNAN, Colleen M; YUFENG TIAN et al.Clinical cancer research. 2007, Vol 13, Num 11, pp 3191-3197, issn 1078-0432, 7 p.Article

Malignant mediastinal germ cell tumors : An intergroup study. DiscussionBILLMIRE, Deborah; VINOCUR, Charles; GEIGER, J et al.Journal of pediatric surgery. 2001, Vol 36, Num 1, pp 18-24, issn 0022-3468Article

MYCN expression is not prognostic of adverse outcome in advanced-stage Neuroblastoma with nonamplified MYCNCOHN, Susan L; LONDON, Wendy B; DONGHUI HUANG et al.Journal of clinical oncology. 2000, Vol 18, Num 21, pp 3604-3613, issn 0732-183XArticle

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG projectANGELINI, Paola; LONDON, Wendy B; IRWIN, Meredith S et al.European journal of cancer (1990). 2012, Vol 48, Num 8, pp 1185-1191, issn 0959-8049, 7 p.Article

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 ImmunotherapyDELGADO, David C; HANK, Jacquelyn A; YANG, Richard et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 23, pp 9554-9561, issn 0008-5472, 8 p.Article

Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma: rs1800795 (Promoter) and rs8192284 (Receptor)LAGMAY, Joanne P; LONDON, Wendy B; HALL, Brett et al.Clinical cancer research (Print). 2009, Vol 15, Num 16, pp 5234-5239, issn 1078-0432, 6 p.Article

Amifostine Does Not Prevent Platinum-Induced Hearing Loss Associated With the Treatment of Children With Hepatoblastoma: A Report of the Intergroup Hepatoblastoma Study P9645 as a Part of the Children's Oncology GroupKATZENSTEIN, Howard M; CHANG, Kay W; KRAILO, Mark et al.Cancer. 2009, Vol 115, Num 24, pp 5828-5835, issn 0008-543X, 8 p.Article

Prognostic factors in children with extragonadal malignant germ cell tumors : A pediatric intergroup studyMARINA, Neyssa; LONDON, Wendy B; LINDSAY FRAZIER, A et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2544-2548, issn 0732-183X, 5 p.Article

Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma: Results of pediatric oncology group (now children's oncology group) study 9486RODRIGUEZ-GALINDO, Carlos; WOFFORD, Marcia; CASTLEBERRY, Robert P et al.Cancer. 2005, Vol 103, Num 4, pp 850-857, issn 0008-543X, 8 p.Article

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A Pediatric intergroup study-pediatric Oncology Group 9049 and Children's cancer Group 8882GUSHING, Barbara; GILLER, Roger; VINOCUR, Charles D et al.Journal of clinical oncology. 2004, Vol 22, Num 13, pp 2691-2700, issn 0732-183X, 10 p.Article

Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: A Pediatric Oncology group studyKRETSCHMAR, Cynthia S; KLETZEL, Morris; MURRAY, Kevin et al.Journal of clinical oncology. 2004, Vol 22, Num 20, pp 4119-4126, issn 0732-183X, 8 p.Article

p16/p14^ARF cell cycle regulatory pathways in primary neuroblastoma : p16 expression is associated with advanced stage diseaseOMURA-MINAMISAWA, Motoko; DICCIANNI, Mitchell B; CHANG, Ray C et al.Clinical cancer research. 2001, Vol 7, Num 11, pp 3481-3490, issn 1078-0432Article

Metastatic Neuroblastoma Confined to Distant Lymph Nodes (stage 4N) Predicts Outcome in Patients With Stage 4 Disease: A Study From the International Neuroblastoma Risk Group DatabaseMORGENSTERN, Daniel A; LONDON, Wendy B; COHN, Susan L et al.Journal of clinical oncology. 2014, Vol 32, Num 12, pp 1228-1235, issn 0732-183X, 8 p.Article

Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641STROTHER, Douglas R; LONDON, Wendy B; MURRAY, Kevin et al.Journal of clinical oncology. 2012, Vol 30, Num 15, pp 1842-1848, issn 0732-183X, 7 p.Article

Overcoming reprogramming resistance of Fanconi anemia cellsMÜLLER, Lars U. W; MILSOM, Michael D; STRAIT, Kelly et al.Blood. 2012, Vol 119, Num 23, pp 5449-5457, issn 0006-4971, 9 p.Article

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425SCHWARTZ, Cindy L; CONSTINE, Louis S; VILLALUNA, Doojduen et al.Blood. 2009, Vol 114, Num 10, pp 2051-2059, issn 0006-4971, 9 p.Article

Copy number variation at 1q21.1 associated with neuroblastomaDISKIN, Sharon J; CUIPING HOU; PECOR, Katlyn et al.Nature (London). 2009, Vol 459, Num 7249, pp 987-991, issn 0028-0836, 5 p.Article

Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma : A Report From the International Neuroblastoma Risk Group DatabaseBAGATELL, Rochelle; BECK-POPOVIC, Maja; LONDON, Wendy B et al.Journal of clinical oncology. 2009, Vol 27, Num 3, pp 365-370, issn 0732-183X, 6 p.Article